SITE-SPECIFIC CONJUGATION OF ZIRCONIUM AND COPPER COMPLEXES TO ANTIBODIES FOR APPLICATION IN DIAGNOSTIC IMAGING AND THERAPY
Grant number: FT130100204 | Funding period: 2014 - 2017
This project will focus on fundamental chemistry that underpins innovations in the synthesis of metal-based imaging and therapeutic agents. Radioactive isotopes of copper and zirconium can be used for either non-invasive diagnostic imaging or treatment of disease. However, it is essential that the diagnostic or therapeutic agent selectively localises in diseased tissue. This project aims to achieve the required selectivity by employing enzymatic site-specific bioconjugation reactions to build new imaging agents that feature ligands designed to safely bind radioactive isotopes fused to antibody derived targeting molecules.